CHRIS AMOS to Erlotinib Hydrochloride
This is a "connection" page, showing publications CHRIS AMOS has written about Erlotinib Hydrochloride.
Connection Strength
0.162
-
An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors. Int J Cancer. 2020 11 01; 147(9):2621-2633.
Score: 0.162
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.